Microbiota in health and diseases K Hou, ZX Wu, XY Chen, JQ Wang, D Zhang, C Xiao, D Zhu, JB Koya, ... Signal transduction and targeted therapy 7 (1), 1-28, 2022 | 959 | 2022 |
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer L Zhang, Y Li, Q Wang, Z Chen, X Li, Z Wu, C Hu, D Liao, W Zhang, ... Molecular Cancer 19, 1-18, 2020 | 96 | 2020 |
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications H Song, D Liu, S Dong, L Zeng, Z Wu, P Zhao, L Zhang, ZS Chen, C Zou Signal transduction and targeted therapy 5 (1), 193, 2020 | 88 | 2020 |
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19 ZN Lei, ZX Wu, S Dong, DH Yang, L Zhang, Z Ke, C Zou, ZS Chen Pharmacology & Therapeutics 216, 107672, 2020 | 86 | 2020 |
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates JQ Wang, ZX Wu, Y Yang, QX Teng, YD Li, ZN Lei, KA Jani, N Kaushal, ... Journal of Evidence‐Based Medicine 14 (3), 232-256, 2021 | 84 | 2021 |
Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges VP Chavda, AB Patel, KJ Mistry, SF Suthar, ZX Wu, ZS Chen, K Hou Frontiers in oncology 12, 867655, 2022 | 76 | 2022 |
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function L Gao, ZX Wu, YG Assaraf, ZS Chen, L Wang Drug Resistance Updates 57, 100770, 2021 | 75 | 2021 |
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies ZD Shi, K Pang, ZX Wu, Y Dong, L Hao, JX Qin, W Wang, ZS Chen, ... Signal Transduction and Targeted Therapy 8 (1), 113, 2023 | 72 | 2023 |
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells ZX Wu, QX Teng, CY Cai, JQ Wang, ZN Lei, Y Yang, YF Fan, JY Zhang, ... Biochemical pharmacology 166, 120-127, 2019 | 59 | 2019 |
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer Z Shi, L Hao, X Han, ZX Wu, K Pang, Y Dong, J Qin, G Wang, X Zhang, ... Molecular Cancer 21 (1), 37, 2022 | 57 | 2022 |
Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression Z Pan, K Wang, X Wang, Z Jia, Y Yang, Y Duan, L Huang, ZX Wu, J Zhang, ... Molecular Cancer 21 (1), 77, 2022 | 50 | 2022 |
Tivantinib, A c-met inhibitor in clinical trials, is susceptible to ABCG2-mediated drug resistance ZX Wu, Y Yang, QX Teng, JQ Wang, ZN Lei, JQ Wang, S Lusvarghi, ... Cancers 12 (1), 186, 2020 | 42 | 2020 |
Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells W Feng, M Zhang, ZX Wu, JQ Wang, XD Dong, Y Yang, QX Teng, ... Frontiers in oncology 10, 955, 2020 | 38 | 2020 |
Overexpression of ABCB1 transporter confers resistance to mTOR inhibitor WYE-354 in cancer cells J Wang, DH Yang, Y Yang, JQ Wang, CY Cai, ZN Lei, QX Teng, ZX Wu, ... International journal of molecular sciences 21 (4), 1387, 2020 | 37 | 2020 |
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy K Pang, W Wang, JX Qin, ZD Shi, L Hao, YY Ma, H Xu, ZX Wu, D Pan, ... MedComm 3 (4), e175, 2022 | 34 | 2022 |
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro Y Yang, N Ji, QX Teng, CY Cai, JQ Wang, ZX Wu, ZN Lei, S Lusvarghi, ... Frontiers in oncology 10, 700, 2020 | 34 | 2020 |
Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells ZX Wu, Y Yang, G Wang, JQ Wang, QX Teng, L Sun, ZN Lei, L Lin, ... Cancer Science 111 (8), 2872-2882, 2020 | 32 | 2020 |
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study N Ji, Y Yang, CY Cai, JQ Wang, ZN Lei, ZX Wu, Q Cui, DH Yang, ZS Chen, ... Frontiers in oncology 9, 514, 2019 | 32 | 2019 |
Overexpression of ABCC1 confers drug resistance to betulin XY Chen, Y Yang, JQ Wang, ZX Wu, J Li, ZS Chen Frontiers in oncology 11, 640656, 2021 | 28 | 2021 |
Microbiota in health and diseases., 2022, 7 K Hou, ZX Wu, XY Chen, JQ Wang, D Zhang, C Xiao, D Zhu, JB Koya, ... DOI: https://doi. org/10.1038/s41392-022-00974-4, 135, 0 | 28 | |